Biontech stock latest news

BioNTech SE (BNTX)

BioNTech SE is an equity-listed company in the US market.

Current price: USD 113.1. Price change: Change of USD 17.46 (0.18%) compared to the previous closing price.

The last opening price was USD 106.66, and the intraday volume was 5260,449.

The intraday high was USD 115.9 and the intraday low was USD 95.4.

Last trading time: Tuesday, June 3, 02:15:00 +0530.

BioNTech (NASDAQ: BNTX) stock experienced a remarkable 18% price increase on June 2, 2025, closing at USD 113.10. This increase is due to a significant partnership with Bristol Myers Squibb (BMS), which plans to jointly develop and commercialize the cancer drug BNT327. The deal includes an upfront payment of USD 1.5 billion, an additional USD 2 billion through 2028, and potential milestone payments of up to USD 7.6 billion.

BNT327 is a bispecific antibody targeting the proteins PD-L1 and VEGF-A and is being tested in over 20 clinical trials, including two Phase 3 trials. The drug is showing promising results in the treatment of lung and breast cancer.

This partnership strengthens BioNTech's position in oncology and demonstrates its commitment to developing innovative therapies beyond COVID-19 vaccine development. The collaboration with BMS allows both companies to combine their expertise and fully realize the potential of BNT327.